Andere Sprachen Beximco Pharmaceuticals Limited London S.E.

Aktien

A0ETTX

US0885792061

BXP

Verzögert London S.E. Andere Börsenplätze 10:00:13 17.05.2024			% 5 Tage	% 1. Jan.
40,8 ^GBX	+0,74 %		+4,62 %	-1,69 %

30.04.	GEWINNE UND HANDEL: Software Circle & Beximco berichten über höhere Umsätze	AN
30.04.	Beximco Pharmaceuticals Limited meldet die Ergebnisse für das dritte Quartal und die neun Monate bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	30.04.
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	30.04.
Beximco names Iqbal Ahmed as managing director	04.03.
Beximco Pharmaceuticals to strengthen portfolio as interim profit up	30.01.
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023	30.01.
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	30.01.
Beximco MD steps down to join Bangladeshi cabinet	11.01.
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Member of the Board	11.01.
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Managing Director	11.01.
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue	06.11.
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	06.11.
Beximco boosts revenue in local currency but profit falls	01.11.
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	01.11.
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023	20.10.23
Beximco working to fix deficiencies at manufacturing plant	11.09.23
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit	11.09.23
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows	02.05.23
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	02.05.23
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view	30.01.23
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	30.01.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Beximco Pharmaceuticals Limited London S.E.

Aktien

A0ETTX

US0885792061

BXP

Andere Sprachen

Filter